Goeman, C.J. 2017. The Price Isn’t Right: Shareholder Proposals as Opportunities for Institutional Investors to Restore Firm Value and Reduce Pharmaceutical Prices. Columbia Business Law Review. 2017, 2 (Aug. 2017), 748–806. DOI:https://doi.org/10.7916/cblr.v2017i2.1723.